2018 tables: Institutions - chemistry - corporate

The 2018 tables are based on Nature Index data from 1 January 2017 to 31 December 2017.

Table criteria

# Institution Share 2016 Share 2017 Count 2017 Change in Adjusted Share 2016-2017*
1 Merck & Co., Inc., United States of America (USA) 23.35 22.44 32 -10.3%
2 IBM Corporation, United States of America (USA) 15.97 17.77 46 3.8%
3 Pfizer Inc., United States of America (USA) 13.69 13.24 28 -9.7%
4 Bristol-Myers Squibb (BMS), United States of America (USA) 3.96 11.35 25 167.6%
5 Dow Inc., United States of America (USA) 6.49 9.73 22 39.8%
6 Johnson & Johnson, United States of America (USA) 2.65 6.09 12 114.2%
7 Eli Lilly and Company, United States of America (USA) 1.76 5.74 14 204.3%
8 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 2.40 5.33 18 107.6%
9 Bruker Corporation, United States of America (USA) 3.42 4.90 24 33.5%
10 Thermo Fisher Scientific Inc., United States of America (USA) 6.18 4.37 22 -33.9%
11 AbbVie Inc., United States of America (USA) 2.03 4.21 7 93.7%
12 Amgen Inc., United States of America (USA) 6.87 3.55 7 -51.7%
13 Waters Corporation, United States of America (USA) 2.02 2.85 10 31.7%
14 Biogen Inc., United States of America (USA) 1.80 2.55 4 32.2%
15 Agilent Technologies, Inc., United States of America (USA) 1.83 2.29 9 16.4%
16 Western Digital Corporation, United States of America (USA) 1.00 2.21 6 106.4%
17 Seattle Genetics, Inc., United States of America (USA) 2.00 2.00 2 -6.7%
18 Microsoft Corporation, United States of America (USA) 0.98 1.72 8 63.6%
19 Danaher Corporation, United States of America (USA) 1.14 1.59 4 30.8%
20 Alnylam Pharmaceuticals, Inc., United States of America (USA) 0.46 1.39 2 182.2%
21 Chevron Corporation, United States of America (USA) 1.12 1.28 10 6.4%
22 Regeneron Pharmaceuticals, Inc., United States of America (USA) 1.03 2 N/A
23 Momenta Pharmaceuticals, Inc., United States of America (USA) 1.00 1.00 1 -6.7%
23 Amicus Therapeutics, Inc., United States of America (USA) 1.00 1 N/A
23 Eastman Kodak Company, United States of America (USA) 1.00 1 N/A
24 Intel Corporation, United States of America (USA) 0.19 0.97 10 383.9%
25 Northrop Grumman Corporation, United States of America (USA) 0.10 0.95 10 756.6%
26 JEOL USA, Inc., United States of America (USA) 0.07 0.93 2 1,113.4%
27 Leidos Holdings, Inc., United States of America (USA) 1.00 0.91 7 -15.5%
28 Schlumberger Limited, United States of America (USA) 0.25 0.88 3 226.7%
29 480 Biomedical, Inc., United States of America (USA) 0.85 1 N/A
30 Snapdragon Chemistry Inc., United States of America (USA) 0.83 1 N/A
31 General Electric Company (GE), United States of America (USA) 0.79 5 N/A
32 Applied Materials, Inc., United States of America (USA) 0.15 0.76 13 375.9%
33 Firebird Biomolecular Sciences, LLC, United States of America (USA) 0.50 0.75 1 40.0%
33 HRL Laboratories LLC, United States of America (USA) 2.31 0.75 1 -69.7%
34 Afton Chemical Corporation, United States of America (USA) 0.50 0.70 2 30.7%
35 Aramco Research Center in Houston Area, United States of America (USA) 0.67 1 N/A
36 New England Biolabs, Inc. (NEB), United States of America (USA) 1.33 0.65 2 -54.2%
37 Boeing Company, United States of America (USA) 0.09 0.60 1 516.0%
37 SomaLogic, Inc., United States of America (USA) 0.40 0.60 1 40.0%
38 Engineering Research and Consulting, Inc. (ERC), United States of America (USA) 0.55 4 N/A
39 Alphabet Inc., United States of America (USA) 0.54 2 N/A
40 General Motors (GM), United States of America (USA) 1.14 0.54 4 -55.8%
41 Excet, Inc., United States of America (USA) 0.11 0.50 1 320.0%
41 OndaVia, Inc., United States of America (USA) 0.50 1 N/A
41 Glycan Therapeutics, LLC, United States of America (USA) 0.50 1 N/A
41 AM Biotechnologies, LLC, United States of America (USA) 0.50 1 N/A
42 ConfometRx, United States of America (USA) 0.45 1 N/A
43 Molecular Vista, United States of America (USA) 0.25 0.44 2 65.9%
44 Laboratory Corporation of America Holdings (LabCorp), United States of America (USA) 0.43 1 N/A
45 Advanced Energy Materials, LLC, United States of America (USA) 0.42 1 N/A
46 Genomatica, Inc., United States of America (USA) 0.41 1 N/A
47 Gaussian, Inc., United States of America (USA) 0.40 1 N/A
47 The Sherwin-Williams Company, United States of America (USA) 0.40 1 N/A
48 PLANT PV Inc., United States of America (USA) 0.39 1 N/A
48 NuMat Technologies, United States of America (USA) 1.18 0.39 1 -69.3%
49 Lintec of America, Inc., United States of America (USA) 0.40 0.38 3 -11.1%
50 Xerion Advanced Battery Corp., United States of America (USA) 0.19 0.38 1 85.3%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.